Pendulum is committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases. Our targeted formulations of natural bacterial strains help to rebalance the microbiome which restores and improves one’s health. Pendulum Glucose Control is a probiotic medical food designed to help minimize blood sugar spikes and lower A1C in people with type 2 diabetes compared to placebo.
Founded and based in San Francisco, we’re a team of scientists, doctors, and innovators. But more than that, we’re a team with passion and purpose. Driven by finding improvements to managing chronic illnesses through the microbiome, Pendulum is empowering people with groundbreaking products and tools to achieve long-term health. We’re starting with type 2 diabetes and a new, scientifically anchored approach that starts inside the gut. A new reality is possible for those affected by type 2 diabetes. Our team takes pride in pioneering revolutionary solutions that people deserve to reclaim control of their health.
B2C
51 to 100
Series C
$111.2 M
Scaling Up
2013
Pharmaceuticals and Medical Products
Pharmaceuticals
Biotechnology
86% Lowered A1C
79 % Lowered Glucose
86% Improved Health
72% Reduced Sugar Cravings
Increase Efficiency
Sales
Production
Yes
Active
Machine Learning
N/A
Software
N/A
Senior Data Scientist, R&D
San Francisco, California
Lead Data Scientist, R and D
San Francisco, California
Quality Engineer
San Francisco, California
QC Technician I
San Francisco, California
QC Analyst
San Francisco, California
Want to work at Pendulum Therapeutics?
We can introduce you to the right person at Pendulum Therapeutics
4
1
$54M
Company was founded 2013 and it took almost 8 years (Apr 2021) to raise first external round
Interested in researching Pendulum Therapeutics?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Pendulum Therapeutics
Interested in what they do or partnership?
Learn more about how they work